Accelerate biotechnology

Batavia Biosciences teams up with international consortium to support polio eradication

Leiden, 16 January 2018 – Today Batavia Biosciences announces its partnership with an international consortium coordinated by PATH aiming to develop and manufacture safer novel oral poliovirus vaccines (nOPV). The project, funded by the Bill & Melinda Gates Foundation, has the potential to bolster efforts to sustain a polio-free world after the disease has been…


Menzo Havenga awarded CEO of the year 2017 the Netherlands

We are very proud that the prestigious organization “CEO Monthly” has awarded the title of “CEO of the Year 2017 – Netherlands” to our Chief Executive Officer, Menzo Havenga. Menzo was chosen on merit, and a clear vision and strategy. The selection of CEO of the Year is based on a combination of external votes…


We won FD Gazelle Award 2017!

Yesterday, Batavia Biosciences has been awarded with an FD Gazelle Award 2017 by the leading Dutch financial newspaper, Financieel Dagblad as one of the fastest growing mid-sized companies of the Netherlands. It is the third time we have won a FD Gazelle Award and we hope that many more will follow.


Batavia Biosciences teams up with international gene therapy consortium under Horizon2020 program

An international consortium, headed by the group of Prof. Dr. Frank Staal (Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre) has been awarded a €6 million grant from the European Union to develop a gene therapy procedure for newborns suffering from severe combined immunodeficiency syndrome (SCID). According to Prof. Dr. Frank Staal, the development…


Wouter van Catz is Best Biopharmaceutical CFO

We congratulate our Director Finance, Wouter van Catz with being awarded Best Biopharmaceutical CFO of the Benelux in the Global CFO Excellence Awards 2017. These awards have been established to recognize CFO’s whose efforts give rise to the success of the firm. According to the voters of respected industry partners and CFO Monthly‘s own rigorous in-house…


Collaboration between Batavia Biosciences and UGA Biopharma

Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing monoclonal cell lines are now delivered. They were developed and validated by Batavia Biosciences using STEP® technology, and were guided by UGA Biopharma´s in-depth knowledge and experience in the development…


Novel plasmid technology at PEGS Boston

Our Director Operations, Marco Cacciuttolo, presented interesting new case studies for our STEP® Technology at the PEGS summit in Boston . For various ‘difficult to express proteins’ Batavia Biosciences was able to significantly increase product yields in CHO cells. Missed the presentation and interested in receiving more information? Please visit our booth or contact us at info@bataviabiosciences.com.


How to improve Dutch life sciences landscape of translational research?

Batavia Biosciences hosted the Medical Delta Café: From ‘Bench to Bin’? Delegates representing Dutch industry, academia, technology transfer offices, government and funders came together to discuss the relatively high failure rate (and potential solutions) in the Dutch life sciences landscape of translational research. Read what we can learn from the successes of Harvard Medical School…


Univercells and consortium partners Batavia Biosciences and Natrix Separations Received $12 Million Grant by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries

Univercells and consortium partners Batavia Biosciences and Natrix Separations selected by Bill & Melinda Gates Foundation to Radically Reduce Vaccine Costs for Developing Countries   Brussels, Belgium, December 15, 2016 – Univercells announced today that it has been awarded a $12 million grant by the Bill & Melinda Gates Foundation for the development of a breakthrough vaccine manufacturing…